GLP-1 receptor agonist reduces anthracycline– and trastuzumab–induced cardiac dysfunction and systemic hs-CRP, IL-1β and IL-6 in non-diabetic preclinical models
31 August 2026 (08:15 - 08:45)
Organised by: 
Abstract
About the speaker
National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)
4 More presentations in this session
Mrs G. Brandao (Botucatu, BR)
Miss A. Santos (Botucatu, BR)
Access the full session
The Event
ESC Congress 2026
31 August 2026
08:15 CET
You may be interested in
ESC Journals
Congress Presentation
